Search

everythinglearnresearchcommunity

for

Search:↓

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

The Swedish neonatal screening program effectively detects PKU, galactosaemia, and biotinidase deficiency with low false positives.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

The boy's severe skin disorder is caused by two new mutations in his TGM1 gene.

FGF5s can block the effects of FGF5, which may help control hair growth in cashmere goats.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

GPC1 is important for blood vessel growth in hair follicles and could help treat hair loss.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Potential new drugs for treating PCOS were identified.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

LGR5 helps maintain corneal cell characteristics and prevents unwanted changes by controlling specific cell signaling pathways.

Ritlecitinib was generally well tolerated in children with alopecia areata.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

The optimized Cinchonine gel effectively fights acne bacteria and is safe for twice-daily use.

YWS1903 is safe for pregnant rats at moderate doses but causes fetal issues at high doses.

Ca²⁺-mediated protein citrullination controls cell growth in the CNS and may help treat brain tumors.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Ruxolitinib treatment may cause eyelash growth.

PCR genotyping in cre-loxP mice can be inaccurate due to unintended gene deletions in non-target tissues.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Par3–mInsc and Gαi3 work together to ensure proper cell division orientation in skin development.